Topics

FDA Continues to Support Transparency and Collaboration in Drug Approval Process as the Clinical Data Summary Pilot Concludes

07:26 EDT 26 Mar 2020 | FDA

After receiving useful feedback as part of the Clinical Data Summary Pilot Program, FDA has decided to conclude the pilot. FDA continues to invest in our work with international partners.

Original Article: FDA Continues to Support Transparency and Collaboration in Drug Approval Process as the Clinical Data Summary Pilot Concludes

NEXT ARTICLE

More From BioPortfolio on "FDA Continues to Support Transparency and Collaboration in Drug Approval Process as the Clinical Data Summary Pilot Concludes"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...